How to belong to Japan!

High Quality Tirzepatide GipGLP-1 CAS 2023788-19-2


Contact Information
Contact Erin G
18031140164
$250.00
More Information

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist.

This Ad has been viewed 0 times.